Key steps to advance vaccine manufacturing technology

Emerging Australian biotech company Sementis is engaging with Health Security Systems Australia and Australian universities to enhance the ability of its existing vaccine manufacturing technology to pivot, scale and rapidly deploy in response to emerging health and biosecurity challenges.

The initial 12-month collaboration with Sementis will draw on the company’s long-standing partnership with the University of South Australia as well as expert researchers from the Biomedicine Discovery Institute at Monash University and The Australian National University.


Posted by Patrick Crosling on December 8th, 2022

Interns join DMTC for Land Forces 2022

On the second day of Land Forces 2022, DMTC Ltd hosted a delegate day for its Industry Capability Development program. DMTC’s Delegate Day provided attendees with an opportunity to meet other program participants from across Australia and hear how DMTC’s leadership of capacity-building and technology transfer activities closely aligns with Defence’s focus on increasing opportunities for Australian industry, with the aim of better supporting the warfighter. (more…)

Posted by Harry Baxter on October 8th, 2022 Tagged: , , ,

Rapid diagnostic platform technology commended at Land Forces 2022

A DMTC-led collaboration has been awarded a High Commendation as part of the prestigious Land Forces 2022 Innovation Awards on the first day of the Exposition in Brisbane.

The award of a high commendation recognises the effort of Health Security Systems Australia (a division of DMTC), in partnership with BioCifer Pty Ltd, CSIRO and academic partners University of the Sunshine Coast and The University of Queensland, to develop a rapid diagnostic platform technology that is accelerating point-of-care detection of bacteria and viruses, and providing a capability advantage for deployed ADF personnel. By focussing on addressing the need to build Australian capability in rapid, accurate and low-resource disease detection, this novel technology aims to detect and diagnose multiple pathogens including COVID-19, Nipah virus, Dengue virus, Hendra virus, and bacteria possessing antimicrobial resistance (AMR), which are of concern to both civilian and ADF personnel who travel or are deployed overseas. (more…)

Posted by Patrick Crosling on October 4th, 2022

Come and see us at Land Forces 2022

DMTC will return to the Brisbane Convention and Exhibition Centre for Land Forces 2022. Land Forces 2022, which will be held from 4-6 October 2022, will be a key meeting hub for Australian and international industry, Defence, academia and government, as the Australian Army implements the most substantial period of recapitalisation and optimisation since the Second World War.

DMTC will again have a presence on the exhibition floor, with a standalone booth and a separate pod located on the Department of Defence stand. If you’re interested in DMTC’s portfolio of projects and how DMTC is building sovereign capability in the national interest, please come and visit us at Stand GJ7, Hall 1.

Following the success of our Indo-Pacific 2022 Delegate Day, on Wednesday, 5 October DMTC will be hosting two invitation-only events:

While these events are both invitation-only, DMTC strongly encourage those interested in attending to express interest via the email addresses included in the event pages linked above.

There is still time to register for Land Forces 2022. To register and for more information, follow this link.

Posted by Patrick Crosling on September 13th, 2022 Tagged: , , ,